Bioventus (BVS) Enterprise Value Growth (1y) (2021 - 2026)
Bioventus (BVS) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 174.93% |
| Mar 28, 2026 | -34.51% |
| Dec 31, 2025 | -76.01% |
| Sep 27, 2025 | 79.82% |
| Jun 28, 2025 | 16.53% |
| Mar 29, 2025 | -30.74% |
| Dec 31, 2024 | -137.09% |
| Sep 28, 2024 | -122.53% |
| Jun 29, 2024 | -70.45% |
| Mar 30, 2024 | 341.84% |
| Dec 31, 2023 | -81.39% |
| Sep 30, 2023 | 1,516.68% |
| Jul 1, 2023 | -33.49% |
| Apr 1, 2023 | -87.97% |
| Dec 31, 2022 | -37.93% |
| Oct 1, 2022 | 102.58% |
| Jul 2, 2022 | 150.12% |
| Apr 2, 2022 | 169.56% |
| Dec 31, 2021 | 205.34% |
| Oct 2, 2021 | 26.98% |